Amgen Names Ray Jordan Senior Vice President, Corporate Affairs Read more about Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference Read more about Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference
Amgen To Present At The Morgan Stanley Global Healthcare Conference Read more about Amgen To Present At The Morgan Stanley Global Healthcare Conference
Amgen To Present At The Baird Healthcare Conference Read more about Amgen To Present At The Baird Healthcare Conference
Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer Read more about Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
Amgen's Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83 Read more about Amgen's Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
Amgen Announces Webcast of 2012 Second Quarter Financial Results Read more about Amgen Announces Webcast of 2012 Second Quarter Financial Results
Amgen Announces 2012 Third Quarter Dividend Read more about Amgen Announces 2012 Third Quarter Dividend
Amgen Completes Acquisition of KAI Pharmaceuticals Read more about Amgen Completes Acquisition of KAI Pharmaceuticals
Actress Maura Tierney And Amgen Launch The Chemotherapy: Myths or Facts (TM) Campaign Read more about Actress Maura Tierney And Amgen Launch The Chemotherapy: Myths or Facts (TM) Campaign
